Abstract
1097 Background: Residual disease after neoadjuvant chemotherapy (NAC) in triple negative breast cancer (TNBC) represents poor prognosis. Identification of genes involved in prognosis could lead to...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
